Abstract
Dover developed molecular constructs and the initial in viro data that initiated a structural biology route to the determination of the mode of action of the important anti-TB agent ethionamide used to treat multi-drug resistant infections and its analogue prothionamide used to treat leprosy.
| Original language | English |
|---|---|
| Pages (from-to) | 73-78 |
| Journal | Journal of Experimental Medicine |
| Volume | 204 |
| Issue number | 1 |
| DOIs | |
| Publication status | Published - Jan 2007 |